Difference between revisions of "Part:BBa K2686002:Design"

(→‎Source)
(→‎Design Notes)
 
(6 intermediate revisions by the same user not shown)
Line 7: Line 7:
  
 
===Design Notes===
 
===Design Notes===
−
The HexaHistidine sequence was codon optimized for bacterial expression in E. coli
+
The HexaHistidine sequence (GGGGGGHHHHHHGGGGG) was introduced in between amino acids 43/44 in <bbpart>BBa_K2686001</bbpart> which is shifted by one amino acid downstream compared to the location in <bbpart>BBa_K192000<bbpart> where it would be in between amino acids 42/43 (Moon et al., 2014).
−
 
+
−
 
+
  
 
===Source===
 
===Source===
Line 16: Line 14:
  
 
===References===
 
===References===
 +
Moon, H., Lee, J., Min, J. and Kang, S. (2014). Developing Genetically Engineered Encapsulin Protein Cage Nanoparticles as a Targeted Delivery Nanoplatform. Biomacromolecules, 15(10), pp.3794-3801.

Latest revision as of 23:11, 17 October 2018


Encapsulin protein with HexaHistidine insert


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal BglII site found at 77
    Illegal BglII site found at 492
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    INCOMPATIBLE WITH RFC[1000]
    Illegal SapI.rc site found at 426
    Illegal SapI.rc site found at 457


Design Notes

The HexaHistidine sequence (GGGGGGHHHHHHGGGGG) was introduced in between amino acids 43/44 in BBa_K2686001 which is shifted by one amino acid downstream compared to the location in BBa_K192000